Chandra K Singh
Overview
Explore the profile of Chandra K Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jantip P, Singh C, Klu Y, Ahmad N, Bolling B
J Food Sci
. 2025 Feb;
90(2):e70018.
PMID: 39949260
Increased consumption of nuts is associated with reduced risk of some forms of cancer, including leukemia. Peanut skins are not typically retained during food processing but are a potential source...
2.
Daccache J, Park E, Junejo M, Abdelghaffar M, Hwang E, Mohanty C, et al.
J Allergy Clin Immunol
. 2024 Aug;
154(5):1216-1231.
PMID: 39098508
Background: Noninfectious (inflammatory) cutaneous granulomatous disorders include cutaneous sarcoidosis (CS), granuloma annulare (GA), necrobiosis lipoidica (NL), and necrobiotic xanthogranuloma (NXG). These disorders share macrophage-predominant inflammation histologically, but the inflammatory architecture...
3.
Mohanty C, Singh C, Daccache J, Damsky W, Kendziorski C, Yan D, et al.
J Invest Dermatol
. 2024 Jun;
145(1):109-121.
PMID: 38844128
Granuloma annulare (GA) is an idiopathic condition characterized by granulomatous inflammation in the skin. Prior studies have suggested that GA develops from various triggers, leading to a complex interplay involving...
4.
The role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression
Singh C, Fernandez S, Chhabra G, Zaemisch G, Nihal A, Swanlund J, et al.
Expert Opin Ther Targets
. 2024 Apr;
28(5):419-435.
PMID: 38686865
Introduction: Collagen triple helix repeat containing 1 (CTHRC1) is a protein that has been implicated in pro-migratory pathways, arterial tissue-repair processes, and inhibition of collagen deposition via the regulation of...
5.
Chhabra G, Singh C, Ndiaye M, Su S, Shirley C, Ahmad N
NPJ Precis Oncol
. 2024 Jan;
8(1):6.
PMID: 38184733
Polo-like kinase 1 (PLK1), a serine/threonine kinase, is overexpressed in melanoma and its expression has been associated with poor disease prognosis. PLK1 has been shown to interact with NUMB, a...
6.
Singh C, Mintie C, Ndiaye M, Chhabra G, Roy S, Sullivan R, et al.
Front Immunol
. 2023 Feb;
13:1051472.
PMID: 36741360
Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant health/economic burdens. Existing therapies are not fully effective, necessitating development of new approaches for AD management. Here, we report...
7.
Thornton J, Chhabra G, Singh C, Guzman-Perez G, Shirley C, Ahmad N
Front Oncol
. 2022 May;
12:880876.
PMID: 35515106
Melanoma is one of the seven most common cancers in the United States, and its incidence is still increasing. Since 2011, developments in targeted therapies and immunotherapies have been essential...
8.
Singh C, Denu R, Nihal M, Shabbir M, Garvey D, Huang W, et al.
Prostate
. 2022 Mar;
82(9):957-969.
PMID: 35333404
Background: Identification of novel molecular target(s) is important for designing newer mechanistically driven approaches for the treatment of prostate cancer (PCa), which is one of the main causes of morbidity...
9.
Su S, Chhabra G, Singh C, Ndiaye M, Ahmad N
Transl Oncol
. 2022 Jan;
16:101332.
PMID: 34973570
Polo-like kinase I (PLK1), a cell cycle regulating kinase, has been shown to have oncogenic function in several cancers. Although PLK1 inhibitors, such as BI2536, BI6727 (volasertib) and NMS-1286937 (onvansertib)...
10.
Chhabra G, Singh C, Guzman-Perez G, Ndiaye M, Iczkowski K, Ahmad N
J Invest Dermatol
. 2021 Oct;
142(4):1145-1157.e7.
PMID: 34597611
Novel therapeutic strategies are required for the effective and lasting treatment of metastatic melanoma, one of the deadliest skin malignancies. In this study, we determined the antimelanoma efficacy of 4'-bromo-resveratrol...